26 results about "Disaccharide" patented technology

The invention belongs to the technical field of biology, and particularly relates to Meyerozyma caribba XX2120, and the preservation number of the Meyerozyma caribba XX2120 is GDMCC No: 67777. The invention further relates to a preparation method of the Meyerozyma caribba XX2120. The strain is obtained by taking saccharomycetes X2120 as a starting strain, carrying out ARTP mutagenesis treatment and screening, has relatively strong acid resistance, relatively high salt stress resistance and certain alcohol resistance and aldehyde resistance, can effectively utilize monosaccharide, disaccharide and trisaccharide, has a wide utilization range on carbohydrate and has a relatively good utilization rate on inorganic nitrogen. Moreover, the strain can be used for producing mycoprotein through liquid fermentation by taking Luzhou-flavor distillers' grains as a raw material, and also can be used for performing solid fermentation on the Luzhou-flavor distillers' grains, so that the true protein content of the distillers' grains is increased, the nutritional value of the distillers' grains is improved, and the recycling of distillers' grain resources is effectively promoted.

A stable dry composition is provided. This composition comprises one or more viable microorganisms, at least 50% by weight of one or more hydrolyzed proteins, and less than 10% by weight of one or more sugars selected from the group consisting of monosaccharides, disaccharides, and combinations thereof, each weight percentage based on the total weight of the dry composition. Preferably, the composition contains no monosaccharides or disaccharides. The composition may further comprise one or more oligosaccharides, one or more polysaccharides, one or more carboxylic acid salts, or a combination thereof. The composition may have a viability of at least 1 x 10¹⁰ CFU / g and a loss of viability of less than 1 log unit / g after 84 days at 40°C and 33% relative humidity. Methods for preparing the stable dry composition are also provided.

A Bifidobacterium longum subsp longum produced by a method of growing the Bifidobacterium longum subsp longum in a culture medium, the culture medium containing a fructose disaccharide, FOS or combination thereof. A method for treatment or prevention of inflammatory bowel disease, celiac disease, non-celiac gluten sensitivity, gluten ataxia, dermatitis herpetiformis or wheat allergy in an individual, the method including administering a combination of (i) Bifidobacterium longum subsp longum and (ii) a fructose disaccharide, FOS or a combination thereof to the individual.

Use of a fructose disaccharide or fructooligosaccharide, for increasing protein production in Bifidobacterium longum subsp longum.

The objective of this invention is to provide a means for controlling the proliferation of *Streptobacter* spp. A composition for controlling the proliferation of *Streptobacter* spp. is provided, comprising any one selected from kohlbiose and oligosaccharides with kohlbiose as a constituent sugar. In one embodiment, the composition comprises galactosylkohlbiose as any one selected from kohlbiose and oligosaccharides with kohlbiose as a constituent sugar.

This invention provides a novel technology that allows for a more pronounced citrus fruit flavor in citrus fruit juice-flavored alcoholic beverages containing distilled spirits, where the total concentration of monosaccharides and disaccharides (excluding sugar alcohols) is less than 0.5 g / 100 mL based on the volume of the beverage. [Solution] A citrus fruit juice flavored alcoholic beverage containing distilled spirits as a raw material, wherein the total concentration of monosaccharides and disaccharides excluding sugar alcohols is less than 0.5 g / 100 mL based on the volume of the beverage, and the citrus fruit juice flavored alcoholic beverage contains linalool, nonanal, and neryl acetate.

This invention provides a means for controlling butyrate production in the intestine. The objective of this invention is to provide a means for controlling the proliferation of butyrate-producing bacteria, represented by the genus *Faecalibacterium*. This invention provides a composition for controlling the proliferation of butyrate-producing bacteria, preferably *Faecalibacterium*, comprising any one selected from kohlbiose and oligosaccharides with kohlbiose as a constituent sugar. In one embodiment, the composition comprises galactosylkohlbiose as any one selected from kohlbiose and oligosaccharides with kohlbiose as a constituent sugar.

The present application provides a kind of composite microbial fermentation inoculant, specifically, the fermentation inoculant includes: (a) composite microorganism, wherein the composite microorganism includes at least two kinds of microorganisms, and the microorganism is selected from the following group: bacteria, single-cell fungi, or a combination thereof;(b) saccharide component, wherein the saccharide component includes (b1) monosaccharide, disaccharide or a combination thereof, and (b2) molasses powder;(c) peptone;(d) yeast extract;And (e) optional salt material;Wherein, the fermentation inoculant is a dissolved solid preparation, and the number of viable bacteria in the preparation is 1 billion-100 billion per gram of preparation.The composite microbial fermentation inoculant of the present application has high strain stability, is easy to store and transport, is easy to use, and has low preparation cost.

The present application provides a kind of pharmaceutical composition with lipid-lowering effect, including luteolin, isorhamnetin, 9-hydroxy-4,7-megastigme-3-ketone, lotus leaf base, 3-O-feruloyl quinic acid, kaempferol-3-O-acacia disaccharide-7-O-glucoside, kaempferol-3-O-beta-D-acacia glycoside and ginsenoside Rg1.The composition of example 1 has lipid-lowering efficacy verified by golden hamster hyperlipidemia model and AML12, HepG2 cell fatty degeneration model, the regulation effect of the composition of example 1 on the key target points of AMPK signal pathway and NF-κB signal pathway is verified by using molecular pharmacology experiment, and the mechanism of the composition of example 1 in treating hyperlipidemia by regulating energy metabolism and anti-inflammatory mechanism is described.

This invention relates to coated soft chewable tablets, the soft chewable tablets comprising: a core, in an amount of 60% to 99% by weight of the soft chewable tablet, the core forming a cohesive, unheated mass and comprising: one or more water-soluble fibers, in an amount of 10% to 45% by weight of the core; one or more powdered monosaccharides and / or disaccharides, in an amount of 10% to 45% by weight of the core; one or more texture agents, in an amount of 0.1% to 15% by weight of the core; one or more active ingredients, in an amount of 1% to 60% by weight of the core; and one or more solid syrups, in an amount of up to 20% by weight of the core; and an outer coating surrounding the core, in an amount of 1% to 40% by weight of the soft chewable tablet.

The invention discloses a high-purity medium-chain and long-chain inulin separation method based on sequential simulated moving bed chromatography, and belongs to the technical field of food processing. According to the method, monosaccharide / disaccharide, short-chain inulin and medium-and-long-chain inulin in the chicory extract are successfully separated by using a three-component nine-column sequential simulated moving bed chromatographic separation system, and byproducts such as high-purity medium-and-long-chain inulin and short-chain inulin can be obtained. The high-purity medium-long-chain inulin separation method provided by the invention is high in separation efficiency, three product fractions can be simultaneously obtained in one separation process, and the process is simple and efficient. The high-purity medium-long-chain inulin separation method based on the sequential simulated moving bed chromatography provided by the invention can be continuously operated and is high in automation degree.

Provided are two novel endo-beta-N-acetylglucosaminidases, as well as a method for using the two with a disaccharide linker to prepare a non-natural sugar-engineered antibody, or a fixed-point quantitative antibody drug conjugate based on glycosyl modification, and a use.

The application discloses a preparation method of mixed carbon source derived hierarchical porous carbon. The steps of the preparation method of the mixed carbon source derived hierarchical porous carbon are as follows: firstly, starch and disaccharide are added into N-methylmorpholine-N-oxide aqueous solution and heated to be dissolved; the obtained mixture is melt-blended and extruded through a double screw extruder to prepare uniform mixed granules; then, the granules are subjected to pre-carbonization treatment to obtain a carbon precursor; the carbon precursor is ground into powder, mixed with an activating agent aqueous solution, dried, and subjected to activation carbonization at high temperature; finally, the carbonized product is subjected to acid pickling, water washing and drying to obtain the mixed carbon source derived hierarchical porous carbon electrode material. The disaccharide is white granulated sugar or maltose. The preparation method realizes uniform compounding of multiple carbon sources by using a melt-blending process, has the advantages of easy availability of raw materials and easy scale production, and the prepared product shows excellent electrochemical performance and good cycle stability.

The present application relates to a kind of carbon fat-burning coffee beverage and its preparation method.The raw materials of the carbon fat-burning coffee beverage include composite coffee liquid, carbohydrate absorption inhibition composite system, fat metabolism promotion composite system, auxiliary material and water, the carbohydrate absorption inhibition composite system includes white kidney bean extract, green coffee bean extract and mulberry leaf extract, the fat metabolism promotion composite system includes medium-chain triglyceride and L-carnitine tartrate.In the carbohydrate absorption inhibition composite system, white kidney bean extract (alpha-amylase inhibitor), mulberry leaf extract (DNJ), green coffee bean extract (chlorogenic acid) are respectively targeted at starch, disaccharide, glucose hydrolysis and absorption link, and form full-link carbon interception;In the fat metabolism promotion composite system, medium-chain triglyceride (MCT) provides energy quickly to reduce fat, L-carnitine tartrate accelerates fatty acid beta-oxidation, and both consume stock fat.

This invention relates to a disaccharide exoglycosidase β-agarase with both galactosidase and β-galactosidase activities and its applications, belonging to the field of biotechnology. This invention discloses for the first time a method for developing a β-agarase from *Pseudomonas alterniflora* (…). Pseudoalteromonas An enzyme, ORF0276, and its encoding gene, possessing both galactosidase and disaccharide exonuclease activities, were obtained from the genome of strain Q02 (sp.). This enzyme exhibits strong thermostability, high pH tolerance, and stable physicochemical properties, thus possessing potential for industrial applications. When degrading agar polysaccharide substrates, it can act on the β-1,4 glycosidic bonds of the sugar chains to produce a product primarily composed of neo-agarbiose, which can be used for the industrial preparation of neo-agarbiose (NA2). This research provides a molecular template and theoretical reference for the discovery of such multi-functional tool enzymes.

The present invention relates to a binder composition comprising a) Component A comprising amino acid polymer(s) A1 and b) Component B comprising component B1 selected from the group consisting of pentoses, hexoses, disaccharides of pentoses and / or hexoses and mixtures thereof, wherein the amino acid polymer(s) A1 has(have) a total weight average molecular weight Mw,total of at least 800 g / mol and at most 10.000 g / mol and wherein the binder composition comprises at least 55 wt.-% amino acid polymer(s) A1 based on the total weight of the amino acid poly- mer(s) A1 and component B1.

The application belongs to the technical field of biology and relates to a mutant of a cellulose disaccharide hydrolase from Trichoderma reesei and application thereof. The cellulose disaccharide hydrolase from Trichoderma reesei is TrCel7A, and the mutation sites of the mutant are T97A and / or K166A. The application successfully improves the catalytic activity of the cellulose disaccharide hydrolase through rational design of the cellulose disaccharide hydrolase from Trichoderma reesei.

This technology provides a simple and versatile method for suppressing the shrinkage of food products such as meat and seafood. [Solution] A food muscle fiber and / or collagen shrinkage inhibitor comprising one or more sugar alcohols selected from (a) to (g) below as an active ingredient; (a) sorbitol, (b) reduced starch syrup having a sugar composition of 30-50% by mass of monosaccharides, 20-55% by mass of disaccharides, and 40% by mass or less of trisaccharides or more, (c) reduced starch syrup obtained by reducing starch syrup having a dextrose equivalent of more than 55 and less than 100, (d) reduced starch syrup having a sugar composition of less than 30% by mass of monosaccharides and less than 50% by mass of pentasaccharides or more, (e) reduced starch syrup obtained by reducing starch syrup having a dextrose equivalent of more than 35 and less than 55, (f) reduced starch syrup having a sugar composition of 50% by mass or more of pentasaccharides or more, (g) reduced starch syrup obtained by reducing starch syrup having a dextrose equivalent of 10 to 35.

This invention discloses a functional flavoring with catalytically regulated properties, its preparation method, and its application, belonging to the field of flavoring technology. Addressing the core shortcomings of existing caramelized flavoring products—uncontrollable aromas, limited flavor profiles, and inability to be customized—this invention uses food-grade monosaccharide / disaccharide monomers as the sugar source and nitrogen-free acidic, alkaline, or buffered compounds as catalysts to conduct a pure caramelization reaction in a pure aqueous system under normal pressure. No nitrogen-containing amino sources are added throughout the process, completely eliminating Maillard reactions, lowering the reaction temperature, and preventing the formation of harmful byproducts such as 4-methylimidazole.

The present invention relates to a process for the production and separation of 5-hydroxymethylfurfural (HMF) comprising the steps of: (1) dehydrating at least one saccharide selected from the group consisting of monosaccharides having 6 carbon atoms and disaccharides, oligosaccharides and polysaccharides formed from units having 6 carbon atoms or mixtures thereof, in the presence of water and of at least one quaternary ammonium salt, at a temperature between 80-130° C., obtaining a reaction mixture comprising the quaternary ammonium salt, HMF and any unreacted saccharide; and (2) subjecting the said reaction mixture to at least one membrane separation operation selected in the group consisting of nanofiltration, reverse osmosis, electrodialysis and their combinations, obtaining an aqueous permeate comprising HMF and a retentate comprising quaternary ammonium salt, wherein both the dehydration of step (1) and the separation operations of step (2) are carried out in the absence of organic solvents.

The application relates to a seed treatment composition and a preparation method and application thereof, which comprises, taking the total mass of the composition as 100%, 0.3-0.8% of gamma-aminobutyric acid, 1-3% of N-acyl glutamate, 0.5-2.5% of a betaine surfactant, 0.5-2.5% of a water-retaining agent, 0.2-1% of a fatty acid methyl ester sulfonate, 0.5-2.5% of a carboxymethyl cellulose salt, 1-40% of a pesticide, 1-5% of a dispersing agent and the balance of water; wherein the preparation method of the water-retaining agent comprises the following steps: S1, dissolving a cationic polysaccharide in an acidic aqueous solution to form a polysaccharide solution; S2, mixing a non-reducing disaccharide with the polysaccharide solution to form a uniform mixed solution; and S3, freeze-drying the mixed solution to obtain the water-retaining agent. The seed treatment composition provided by the application has good water-retaining performance, comprehensive stress resistance and good compatibility with a seed coating agent system.

The objective of this invention is to provide a means for controlling the proliferation of bacteria of the genus *Subdoligranulum*. A composition for controlling the proliferation of bacteria of the genus *Subdoligranulum* comprises any one selected from squalene and oligosaccharides with squalene as a constituent sugar. In one embodiment, the composition comprises galactosylsqualene as any one selected from squalene and oligosaccharides with squalene as a constituent sugar.

The present application is in the field of dried compositions of non-Saccharomyces yeasts, processes for preparing such compositions by freeze-drying, and compositions that can be prepared by such processes. The process is characterized in that the freeze-drying protective agent comprises maltodextrin, one or more antioxidants, and one or more disaccharides, and the dry weight ratio of the freeze-drying protective agent to the yeast biomass is 0.5:1 to 4:1, preferably 0.5:1 to 3:1.